Sisram Medical, an Israeli aesthetic laser company, completed a $125 million IPO in Hong Kong at the low end of the range. Sisram is majority owned (66%) by Fosun Pharma. Because retail investors were especially interested in the offering, their allocation was increased to 30% of the offering, up from a planned 10%. Sisram, whose stock price has traded steady to slightly lower since the offering, is the first Israeli company to be listed in Hong Kong.
Source: China Biotoday
